DA32 Life Science Tech Acquisition Corp.

Share · US23312M1062 · DALS (XNAS)

Overview

No Price

n/a

Share Float & Liquidity

Free Float -

Shares Float -

Shares Outstanding 25,65 M

Company Profile for DA32 Life Science Tech Acquisition Corp. Share

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

AI Analysis of DA32 Life Science Tech Acquisition Corp.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of DA32 Life Science Tech Acquisition Corp.

No AI threads available for this company yet.

Company Data

Name DA32 Life Science Tech Acquisition Corp.

Company DA32 Life Science Tech Acquisition Corp.

Symbol DALS

Primary Exchange

NASDAQ

ISIN US23312M1062

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Steven Kafka

Market Capitalization 264 Mio

Country United States of America

Currency USD

Employees -

Address 345 Park Avenue South, 10010 New York City

IPO Date 2021-07-28

Ticker Symbols

Name	Symbol
NASDAQ	DALS

More Shares

Investors who hold DA32 Life Science Tech Acquisition Corp. also have the following shares in their portfolio:

DUERKOPP ADLER AG Share

Fidelity Intermediate Treasury Bond Index Fund Fund

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog